Abstract: This invention is directed to a composition comprising a substantially purified protein which enhances endogenous stimulus-induced neurotransmitter release, said neurotransmitter being selected from the group consisting of acetylcholine, dopamine or serotonin, said protein having a binding affinity constant of at least 2.9.+-.0.8 nM for tritiated 3,3-bis(4-pyridinylmethyl)-1-phenylindolin-2-one as determined by a Scatchard analysis, and said protein being trypsin sensitive and phospholipase C insensitive.
Abstract: This disclosure relates to a method of treating a neurological dysfunction in a mammal using a combination of at least one neurotransmitter enhancer and at least one serotonin receptor antagonist.
Type:
Grant
Filed:
July 13, 1990
Date of Patent:
December 15, 1992
Assignee:
Du Pont Merck Pharmaceutical Company
Inventors:
Kimi F. De Noble, Victor J. De Noble, Richard A. Earl, Melvyn J. Myers, Victor J. Nickolson